miR-223 and other miRNA's evaluation in chronic kidney disease: Innovative biomarkers and therapeutic tools
microRNAs (miRNAs) represent a recent breakthrough regarding gene expression regulation. They are instrumental players known to regulate post-transcriptional expression. miRNAs are short single stranded RNAs that base-pair with target mRNAs in specific regions mainly within their 3′ untranslated reg...
Main Authors: | Valérie Metzinger-Le Meuth, Laurent Metzinger |
---|---|
Format: | Article |
Language: | English |
Published: |
KeAi Communications Co., Ltd.
2019-03-01
|
Series: | Non-coding RNA Research |
Online Access: | http://www.sciencedirect.com/science/article/pii/S246805401830091X |
Similar Items
-
The Non-coding MicroRNA-223 is a Promising Biomarker of Chronic Kidney Disease
by: Valérie Metzinger-Le Meuth, et al.
Published: (2021-07-01) -
Inorganic phosphate accelerates the migration of vascular smooth muscle cells: evidence for the involvement of miR-223.
by: Ashraf Yusuf Rangrez, et al.
Published: (2012-01-01) -
Uremic Toxins Affect Erythropoiesis during the Course of Chronic Kidney Disease: A Review
by: Eya Hamza, et al.
Published: (2020-09-01) -
miR-126 Is Involved in Vascular Remodeling under Laminar Shear Stress
by: Ana Mondadori dos Santos, et al.
Published: (2015-01-01) -
miRNA-197 and miRNA-223 Predict Cardiovascular Death in a Cohort of Patients with Symptomatic Coronary Artery Disease.
by: Christian Schulte, et al.
Published: (2015-01-01)